Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamazaki 2641, Noda-shi, Chiba-ken 278-8510, Japan
2.
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamazaki 2641, Noda-shi, Chiba-ken 278-8510, Japan
3.
Department of Genomic Medical Science, Research Institute of Science and Technology (RIST), Tokyo University of Science, Yamazaki 2641, Noda-shi, Chiba-ken 278-8510, Japan
Received:
12 November 2019
Accepted:
27 February 2020
Published:
02 March 2020
Cancer is widely known as a “genetic disease” because almost all cancers involve genomic mutations. However, cancer could also be referred to as a metabolic disease because it mainly depends on glycolysis to produce adenosine triphosphate (ATP) and is frequently accompanied by dysfunctions in the mitochondria, which are the primary organelle required in all eukaryotic cells. Importantly, almost all (99%) mitochondrial proteins are encoded by host nuclear genes. Not only cancer but also aging-related diseases, including neurodegenerative diseases, are associated with a decline in mitochondrial functions. Importantly, the nicotinamide adenine dinucleotide (NAD+) level decreases with aging. This molecule not only plays important roles in metabolism but also in the DNA repair system. In this article, we review 5′-upstream regions of mitochondrial function-associated genes to discuss the possibility of whether NAD+ is involved in transcriptional regulations. If the expression of these genes declines with aging, this may cause mitochondrial dysfunction. In this regard, cancer could be referred to as a “transcriptional disease”, and if so, novel therapeutics for cancer will need to be developed.
San-Xing Wu, Xin-You Meng .
Dynamics of a delayed predator-prey system with fear effect, herd behavior and disease in the susceptible prey. AIMS Mathematics, 2021, 6(4): 3654-3685.
doi: 10.3934/math.2021218
[2]
Binfeng Xie, Na Zhang .
Influence of fear effect on a Holling type III prey-predator system with the prey refuge. AIMS Mathematics, 2022, 7(2): 1811-1830.
doi: 10.3934/math.2022104
[3]
Fatao Wang, Ruizhi Yang, Yining Xie, Jing Zhao .
Hopf bifurcation in a delayed reaction diffusion predator-prey model with weak Allee effect on prey and fear effect on predator. AIMS Mathematics, 2023, 8(8): 17719-17743.
doi: 10.3934/math.2023905
[4]
Jie Liu, Qinglong Wang, Xuyang Cao, Ting Yu .
Bifurcation and optimal harvesting analysis of a discrete-time predator–prey model with fear and prey refuge effects. AIMS Mathematics, 2024, 9(10): 26283-26306.
doi: 10.3934/math.20241281
[5]
A. Q. Khan, Ibraheem M. Alsulami .
Complicate dynamical analysis of a discrete predator-prey model with a prey refuge. AIMS Mathematics, 2023, 8(7): 15035-15057.
doi: 10.3934/math.2023768
[6]
Xiaoming Su, Jiahui Wang, Adiya Bao .
Stability analysis and chaos control in a discrete predator-prey system with Allee effect, fear effect, and refuge. AIMS Mathematics, 2024, 9(5): 13462-13491.
doi: 10.3934/math.2024656
[7]
Kottakkaran Sooppy Nisar, G Ranjith Kumar, K Ramesh .
The study on the complex nature of a predator-prey model with fractional-order derivatives incorporating refuge and nonlinear prey harvesting. AIMS Mathematics, 2024, 9(5): 13492-13507.
doi: 10.3934/math.2024657
[8]
Weili Kong, Yuanfu Shao .
Bifurcations of a Leslie-Gower predator-prey model with fear, strong Allee effect and hunting cooperation. AIMS Mathematics, 2024, 9(11): 31607-31635.
doi: 10.3934/math.20241520
[9]
Yaping Wang, Yuanfu Shao, Chuanfu Chai .
Dynamics of a predator-prey model with fear effects and gestation delays. AIMS Mathematics, 2023, 8(3): 7535-7559.
doi: 10.3934/math.2023378
[10]
Jing Zhang, Shengmao Fu .
Hopf bifurcation and Turing pattern of a diffusive Rosenzweig-MacArthur model with fear factor. AIMS Mathematics, 2024, 9(11): 32514-32551.
doi: 10.3934/math.20241558
Abstract
Cancer is widely known as a “genetic disease” because almost all cancers involve genomic mutations. However, cancer could also be referred to as a metabolic disease because it mainly depends on glycolysis to produce adenosine triphosphate (ATP) and is frequently accompanied by dysfunctions in the mitochondria, which are the primary organelle required in all eukaryotic cells. Importantly, almost all (99%) mitochondrial proteins are encoded by host nuclear genes. Not only cancer but also aging-related diseases, including neurodegenerative diseases, are associated with a decline in mitochondrial functions. Importantly, the nicotinamide adenine dinucleotide (NAD+) level decreases with aging. This molecule not only plays important roles in metabolism but also in the DNA repair system. In this article, we review 5′-upstream regions of mitochondrial function-associated genes to discuss the possibility of whether NAD+ is involved in transcriptional regulations. If the expression of these genes declines with aging, this may cause mitochondrial dysfunction. In this regard, cancer could be referred to as a “transcriptional disease”, and if so, novel therapeutics for cancer will need to be developed.
1.
Introduction
In population ecology, understanding how predators and primary producers influence nutrient flow relative to each other is important. Ecosystem interactions and predator-prey relationships are governed by predation and the delivery of resource processes. The identification of ecological factors that can alter or control dynamic behavior requires theoretical and experimental research. One way to study these questions is by means of experimental control, and another useful way is via mathematical modeling as well as computer simulations. Over decades of theoretical ecology and biomathematics development, mathematical modeling has become an indispensable tool for scientists in related fields to study ecosystems. Since Lotka [1] and Volterra [2], as cornerstones of theoretical ecology, published the first study of predator-prey dynamics, any species in nature can be a predator or prey, and due to its prevalence, it has become one of the most popular topics for researchers to study [3,4,5]. Besides, because biological resources are renewable and have the most unique development mechanisms, the over-utilization of biological resources and the destruction of the environment by humans will directly affect the balance of the ecosystem. Maintaining ecological balance and meeting humans material needs have attracted the most attention from researchers focused on the scientific management of renewable resource development [6,7,8].
Shelter serves as a defense strategy. It refers broadly to a series of behaviors by prey to avoid predators in order to increase their survival rate. The concept of sanctuary was first developed by Maynard-Smith [9] and Gause et al. [10], and its popularity has been very high, garnering widespread attention from many scholars [11,12,13,14,15]. Sih et al.[16] investigated the effects of prey refuge in a three-species model and concluded that the system's stability is strongly related to the refuge. Also, similar findings can be displayed in [17,18,19,20,21,22]. The two modes of refuge analyzed by Gonzalez-Olivares et al. [17] have diverse stability domains in terms of the parameter space. Qi et al.[21] ensure the stability of the system by varying the strength of the refuge.
Through reviewing a large amount of literature, we begin to consider [23,24] as a basis for the two prey and one predator species that will be modeled in this article. We assume that at a certain time t, the populations of the two prey and one predator are x1(t), x2(t), and y(t), respectively. Based on the above, we construct the following model:
Most species in nature, including humans, are influenced by fear. Fear may cause an abnormal state and behavior to arise. As usual, prey have an innate fear of predators. The ecology of fear is related to combining the optimal behavior of prey and predators with their population densities [25,26]. In view of reality, it is a fact that prey fear predators, which is seen as a psychological effect that can have a lasting impact on prey populations. This psychological influence is often easy to overlook, but it is necessary to consider it in the context of practical ecology [27]. Wang et al. [28] first considered the effect of the fear factor on the model and first proposed the fear of prey F(k,y). Afterwards, some researchers have investigated the effects of the fear effect and predator interferences in some three-dimensional systems as well as explored the generation of Hopf bifurcation conditions in the presence of a fear parameter as a bifurcation parameter [29,30,31,32]. Zanette et al. [33] observed that prey will reduce reproducing because of fear of being killed by predators, thus decreasing the risk of being killed after giving birth, which also leads directly to a decline in prey birth rates. According to the above discussion, our paper considers the different fears ki caused by predators for the two prey species.
In reality, when prey feel the crisis of being hunted, they will reproduce less and increase their survival rate. These conditions about the fear factor F(ki,y)(i=1,2) are listed as follows:
1)F(0,y)=1: prey production does not decrease when the prey does not fear the predator;
2)F(ki,0)=1: even though the prey will develop a fear of predators and there will be no predators, prey production will still not decline;
3)limki→∞F(ki,y)=0: when the prey's fear of the predator is very high, this will result in the prey production tending to zero;
4)limy→∞F(ki,y)=0: prey have a fear of predators, and when predator numbers are too large, this can also lead to prey production tending to zero;
5)∂F(ki,y)∂ki<0: the greater the prey's fear of predators, the less productive it will be;
6)∂F(ki,y)∂y<0: predators are inversely proportional to their prey.
For ease of analysis, we draw on Wang et al. [28] to consider the fear effect:
F(ki,y)=11+kiy(i=1,2),
(1.2)
obviously, F(ki,y)(i=1,2) in (1.2) satisfies conditions 1)–6). Based on the above conditions, this study will consider the effect of fear on system (1.1) to obtain system (1.3).
Notably, most biological parameters in much of the literature are fixed constants. However, in reality, the survival of species is full of unknowns, and all data are not always constant, which can lead to deviations from the ideal model with fixed parameters. In order to make the model more relevant and the results more accurate, we cannot just consider fixed parameters. Therefore, to make the study more convincing, it is necessary to target imprecise parameters. Professor Zadeh [34], who first proposed the fuzzy set theory, also argued that the application of fuzzy differential equations is a more accurate method for modeling biological dynamics in the absence of accurate data conditions [35]. Moreover, the first introduction of the idea of fuzzy derivatives came from Chang and Zadeh [36]. Further, Kaleva [37] studied the generalized fuzzy derivatives based on Hukuhara differentiability, the Zadeh extension principle, and the strong generalized differentiability concept. Bede et al. [38] employed the notion of strongly generalized differentiability to investigate fuzzy differential equations. Khastan and Nieto [39] solved the margin problem for fuzzy differential equations in their article. Motivated by the method of Pal [13] and Wang [23], we assume that the imprecise parameters ~r1, ~r2, ~a1, ~a2, ~c1, ~c2, ~e1, ~e1 and ˜d represent all triangular fuzzy numbers (the relevant theories of fuzzy sets are detailed in Appendix A), then the system (1.3) can be written as
The rest of the paper is shown below: In Section 2, we first prove the nonnegativity and boundedness of the system (1.7). Sections 3 and 4 discuss all possible equilibria and give conditions for the local asymptotic stability and global asymptotic stability of the equilibria. Immediately after that, in Section 5, we analyze the Hopf bifurcation by using the normal form theory. In Section 6, we numerically simulate the theoretical results of Sections 4 and 5. Finally, the article ends with detailed conclusions.
2.
Nonnegativity and boundedness
In this section, we give the following theorem to ensure the boundedness and nonnegativity of the solutions of the system (1.7).
Theorem 2.1.Provided that the initial values x1(0)>0, x2(0)>0, and y(0)>0, all solutions of system (1.7) are nonnegative.
Proof. It is not difficult to find that the right half of the system (1.7) fulfills the local Lipschitzian condition. Integrating both sides of the system (1.7) at the same time yields
If the solution curve starts at any internal point of R3+={(x1(t),x2(t),y(t))∈R3:x1(t)≥0, x2(t)≥0, y(t)≥0}, then x1(t), x2(t), and y(t) will always be nonnegative. □
Theorem 2.2.Assume that the initial values x1(0), x2(0), and y(0) are all greater than zero. The feasible region Ω is a positive invariant set of the system (1.7) defined by
It follows from the Descartes law of signs that Eq (3.4) has one and only one solution y∗ greater than zero if and only if g3>0, i.e., B1>x2K2B2+B3x1+q2E2. Substituting y∗ into the algebra expression on the right side of the first equation of the system (1.7) equals zero; furthermore, we obtain
Reusing the Descartes law of signs, we can assert that there exists at least one positive solution x∗1 of Eq (3.6) if and only if g4g5<0. And then we can deduce that
then the interior equilibrium P7(x∗1,x∗2,y∗) exists.□
4.
Stability analysis
In this section, the Jocabian matrix will be used to prove the local stability of all equilibria. Moreover, we prove the global stability of the internal equilibrium P7 by constructing a Lyapunov function.
4.1. Local stability
The Jocabian matrix for system (1.7) is given below:
The Routh-Hurwitz criterion shows that the internal equilibrium P7 is locally asymptotically stable; the following conditions need to be met: ψ1>0, ψ1ψ2>0, and ψ3>0.□
4.2. Global stability
This subsection studies the global asymptotic stability of interior equilibrium P7.
Theorem 4.2.If condition 4Γ1Γ2l1l2A2B2(1+k1y)(1+k2y) > (l1A3+l2B3)2 (i.e. 4Γ1Γ2l1l2(w1rα1R+w2rα1L)(w1rα2R+w2rα2L)(1+k1y)(1+k2y) > (l1(w1aα1R+w2aα1L)+l2(w1aα2R+w2aα2L))2) holds, then P7 is globally asymptotically stable.
Therefore, dVdt<0 if and only if 4Γ1Γ2l1l2A2B2(1+k1y)(1+k2y)>(l1A3+l2B3)2. □
5.
Hopf bifurcation
In this section, we will use the normal form theory introduced by Hassard et al.[40] and the central manifold theory [41] to study the Hopf bifurcation of the system (1.7). When the system (1.7) undergoes Hopf bifurcation, the corresponding characteristic equation must have a pair of conjugate pure imaginary roots, that is,
η1,2=±iω,i=√−1.
(5.1)
Consider the parameter k1 as a bifurcation parameter. When the value of parameter k1 changes near the critical point kΞ1 of Hopf bifurcation, the pure imaginary roots ±iω will become a complex eigenvalue η=ρ+i˜ω. Substituting η=ρ+i˜ω into Eq (4.12), we need to separate the imaginary and real parts to get
ρ3+ψ3+ρψ2+ρ2ψ1−3ρ˜ω2−ψ1˜ω2=0,
(5.2)
3ρ2˜ω+ψ2˜ω+2ρψ1˜ω−˜ω3=0.
(5.3)
By simplifying Eqs (5.2) and (5.3), we obtain
ψ3−8ρ3−2ρψ2−8ρ2ψ1−ψ1ψ2−2ρψ21=0,
(5.4)
at k1=kΞ1, taking the derivative of Eq (5.4) over k1 yields
If it satisfies dρdk1|k1=kΞ1≠0, the system (1.7) will generate Hopf bifurcation, which indicates that when parameter k1 crosses the bifurcation critical point kΞ1, the population state evolves from stable equilibrium to periodic oscillation over time.
When the system (1.7) undergoes Hopf bifurcation at k1=kΞ1, the final decision condition is also met. Considering that the characteristic roots of Eq (4.12) are η1,2=±iω and η3=−ψ1, in order to obtain this condition, we introduce
z1=x1−x∗1,z2=x2−x∗2,z3=y−y∗.
(5.6)
Substituting (5.6) into the system (1.7) and separating the linear and nonlinear parts, it can be obtained that
where O((|z1|+|z2|+|z3|)4) is a fourth-order polynomial function about variables (|z1|,|z2|,|z3|), while tj1j2j3, nj1j2j3, and lj1j2j3 can be obtained through calculation:
Correspondingly, the dynamic properties of the system are limited to the central flow Wc(0,0,0), and in conjunction with Eq (5.14), system (5.12) can be simplified as
where subscripts y1 and y2 indicate partial derivatives for the first and second variable, respectively. Based on Eq (5.18), it can be obtained that Uy1=0, Uy2≠0, Ny1≠0, Ny2=0, and Uy2Ny1≠0. In addition, it ensures that the system (5.18) has pure virtual feature roots ±i√|Uy2Ny1|. Thus, it can be determined that system (1.7) produces Hopf bifurcation; the direction of the bifurcation is determined by the following equation:
QkΞ1=116ω(ℓ3+ℓ5+ȷ5+ȷ7)+116ω(ℓ1ℓ3−ȷ2ȷ3−ȷ1ȷ2−ȷ1ℓ1).
(5.21)
Theorem 5.1.If dρdk1|k1=kΞ1≠0, then system (1.7) will generate Hopf bifurcation at interior equilibrium P7. In addition, when dρdk1|k1=kΞ1<0, if QkΞ1<0 and 0<k1−kΞ1≪1, then system (1.7) will generate supercritical Hopf bifurcation and form a stable periodic orbit, or if QkΞ1>0 and 0<k1−kΞ1≪1, then system (1.7) will generate subcritical Hopf bifurcation and form a stable periodic orbit.
6.
Numerical simulations
In this section, we first discussed equilibria P1 to P7 of system (1.7) with distinct values of α, w1, and w2. Consider the parameter values as follows: ~r1=(2.8,3,3.2), ~r2=(2.8,3,3.2), ~c1=(0.1,0.2,0.3), ~c2=(0.5,0.6,0.7), ~a1=(0.1,0.2,0.3), ~a2=(0.2,0.3,0.4), ~e1=(0.2,0.3,0.4), ~e2=(0.3,0.4,0.5), and ˜d=(0.1,0.2,0.3). Tables 2–8 showed that the trivial equilibrium P1 retained constant at (0, 0, 0), the values of prey x1, prey x2, and predator y always maintained at 0; the values of prey x1 in P2 and prey x2 in P3 severally decreased with increasing w1 under the same α; the values of prey x1 and predator y in P4 increased with increasing w1, and for P5 the value of prey x2 and predator y rose with growing w1; the values of prey x1 and x2 in P6 decreased with growing w1; and for the same α, considering interior equilibrium P7, the values of prey x1, prey x2, and predator y decreased with growing w1.
Table 2.
The trivial equilibrium P1 for k1=0.1, k2=0.7, q1=0.7, q2=0.5, q3=0.7, E1=0.3, E2=0.2, E3=0.2, K1=5, K2=5, m1=0.9, m2=0.3.
Considering four sets of different initial values, it could be seen from Figure 1 that different orbits eventually converged to the same value, which concluded that the interior equilibrium of the system (1.7) fulfills the character of globally asymptotical stability. Figure 2 plotted the bifurcation graph of system (1.7) with the horizontal coordinates k1, and the Hopf bifurcation of the system occurred with k1 taking values in the range of 0.01≤k1≤0.7. When 0.01≤k1<0.384, the system oscillates periodically, while it maintains a stable steady-state when 0.384<k1≤0.7. Therefore, based on Figure 2, it could be concluded that the fear of prey x1 for predator y affected the stability of the system. We further observed that as k1 increased, the prey x1 density continued to decrease while the predator y density kept increasing. Thus, the result also suggested that greater fear of predators had a negative impact on prey populations while having a positive impact on predator populations. Correspondingly, Figures 3 and 4 showed the waveform plots and phase diagram at k1=0.1 and k1=0.7, respectively.
Figure 1.
Global stability of the internal equilibrium P7 = (5.665, 1.668, 2.047) of system (1.7) is given by the following parameter values: α=1, w1+w2=1, A1=2.0, A2=2.0, B1=2.0, B2=2.0, k1=0.2, k2=0.1, q1=0.4, q2=0.4, q3=0.2, E1=0.2, E2=0.2, E3=0.2, A3=0.1, B3=0.1, A4=0.3, B4=0.6, K1=10, K2=10, m1=0.4, m2=0.4, C1=0.1, C2=0.2, C3=0.5.
In addition, Figure 5 also plots the bifurcation graph with changing m1. As can be seen in Figure 5, m1 took values from 0.3 to 1, in which the system also underwent a Hopf bifurcation. When the value m1 ranged from 0.3 to 0.657, the system (1.7) was stable; nevertheless, it would become unstable at 0.657<m1≤1. Correspondingly, Figures 6 and 7 showed the waveform plots and phase diagram at m1=0.6 and m1=0.9, respectively.
Figure 5.
Hopf bifurcation occurs as a bifurcation parameter of system (1.7) parameter m1, and the remaining parameters take the following values: α=1, w1+w2=1, A1=2.0, A2=2.0, B1=2.0, B2=2.0, k1=0.1, k2=0.4, q1=0.7, q2=0.4, q3=0.2, E1=0.2, E2=0.2, E3=0.3, A3=0.1, B3=0.1, A4=0.3, B4=0.6, K1=10, K2=70, m2=0.4, C1=0.1, C2=0.2, C3=0.5.
Further, we find an interesting dynamic phenomenon through some numerical simulations. System (1.7) appears as a chaotic phenomenon, as shown in Figure 8.
Figure 8.
Waveform plots and phase diagram of chaotic phenomena with the following parameter values: α=1, w1+w2=1, A1=2.0, A2=2.0, B1=3.0, B2=3.0, k1=0.2, k2=0.5, q1=0.6, q2=0.4, q3=0.2, E1=0.2, E2=0.3, E3=0.2, A3=0.2, B3=0.3, A4=0.3, B4=0.6, K1=10, K2=70, m1=0.9, m2=0.3, C1=0.1, C2=0.2, C3=0.5.
In this work, we develop a model of one-predator and two-prey interactions in a fuzzy environment, examine the effects of fear and prey refuge on the system, and provide insight into the dynamic complexity. The proofs of the theoretical parts of this paper are based on system (1.7). It has been proven that all equilibria in system (1.7) are locally asymptotically stable, and interior equilibrium P7 is also globally asymptotically stable. We have been further concerned about the appearance and direction of Hopf bifurcation. With the support of theoretical research, our numerical simulations have been able to display a wealth of charts and graphs.
First of all, different equilibria are displayed from Tables 2–8 with different α,w1,w2, respectively. Throughout Figure 1, we have verified the global asymptotical stability of interior equilibrium P7, and find that the system is from unstable to stable with the increase of fear k1, which demonstrates that the fear effect may be an important factor influencing the stability of the system (see Figures 2–4). Furthermore, it has also been observed that an increase in prey refuge m1 leads to oscillatory phenomena (see Figures 5–7). Finally, through studying the Hopf bifurcation, we have discovered some interesting biological phenomena, namely that system (1.7) appears to be in a chaotic state (see Figure 8).
Author contributions
Xuyang Cao: Conceptualization, Investigation, Methodology, Validation, Writing-original draft, Formal analysis, Software; Qinglong Wang: Conceptualization, Methodology, Formal analysis, Writing-review and editing, Supervision; Jie Liu: Validation, Visualization, Data curation.
Use of AI tools declaration
The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.
Acknowledgments
The authors thank the editor and referees for their careful reading and valuable comments.
The work is supported by the Natural Science Foundation of Hubei Province (No. 2023AFB1095) and the National Natural Science Foundation of China (No. 12101211) and the Program for Innovative Research Team of the Higher Education Institution of Hubei Province (No. T201812) and the Teaching Research Project of Education Department of Hubei Province (No. 2022367) and the Graduate Education Innovation Project of Hubei Minzu University (Nos. MYK2024071, MYK2023042).
Conflict of interest
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Appendix A
Definition 1.[34] Fuzzy set: A fuzzy set ˜ℏ in a universe of discourse S is denoted by the set of pairs
˜ℏ={(s,μ˜ℏ(s)):s∈S},
where the mapping μ˜ℏ:S→[0,1] is the membership function of the fuzzy set ˜ℏ and μ˜ℏ is the membership value or degree of membership of s∈S in the fuzzy set ˜ℏ.
Definition 2.[42] α-cut of fuzzy set: For any α∈(0,1], the α-cut of fuzzy set ˜ℏ defined by ℏα={s:μ˜ℏ(s))≥α} is a crisp set. For α=0 the support of ˜ℏ is defined as ℏ0=Supp(˜ℏ)=¯{s∈R,μ˜ℏ(s)>0}.
Definition 3.[43] Fuzzy number: A fuzzy number satisfying the property S=R is called a convex fuzzy set.
Definition 4.[44] Triangular fuzzy number: A triangular fuzzy number (TFN) ˜ℏ≡(b1,b2,b3) represent fuzzy set of the real line R satisfying the property that the membership function μ˜ℏ:R→[0,1] can be espressed by
Hence, the α-cut of triangular fuzzy number meets boundedness and encapsulation on [ℏL(α),ℏR(α)], in which ℏL(α)=infs:μ˜ℏ(s)≥α=b1+α(b2−b1) and ℏR(α)=sup{s:μ˜ℏ(s)≥α}=b3+α(b3−b2).
Lemma 1.[45] In weighted sum method, wj stands for the weight of jth objective. wjgj represent a utility function for jth objective, and the total utility function π is represented by
π=l∑jwjgj,j=1,2,⋯,l,
where wj>0 and ∑ljwj=1 are satisfied.
Acknowledgments
We are grateful to Takuma Komori, Hikaru Kondo, Yoriko Kirinoki, Naoya Osamura, Kanako Shimono, and Maiko Tanaka for outstanding technical assistance and discussion.
Conflict of interest
The authors declare no conflict of interest.
References
[1]
Kandoth C, McLellan MD, Vandin F, et al. (2013) Mutational landscape and significance across 12 major cancer types. Nature 502: 333-339. doi: 10.1038/nature12634
[2]
Rahman N (2014) Realizing the promise of cancer predisposition genes. Nature 505: 302-308. doi: 10.1038/nature12981
[3]
Aronson S, Rehm H (2015) Building the foundation for genomics in precision medicine. Nature 526: 336-342. doi: 10.1038/nature15816
[4]
Wishart DS, Mandal R, Stanislaus A, et al. (2016) Cancer metabolomics and the human metabolome database. Metabolomics 6: E10.
Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324: 1029-1033. doi: 10.1126/science.1160809
[7]
Seyfried TN, Flores RE, Poff AM, et al. (2014) Cancer as a metabolic disease: implications for novel therapeutics. Carcinogenesis 35: 515-527. doi: 10.1093/carcin/bgt480
[8]
Seyfried TN (2015) Cancer as a mitochondrial metabolic disease. Front Cell Develop Biol 3: 43. doi: 10.3389/fcell.2015.00043
[9]
Vafai SB, Mootha VK (2012) Mitochondrial disorders as windows into an ancient organelle. Nature 491: 374-383. doi: 10.1038/nature11707
[10]
Zhang J, Pavlova NN, Thompson CB (2017) Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J 36: 1302-1315. doi: 10.15252/embj.201696151
[11]
Clunton AA, Lukey MJ, Cerione RA, et al. (2017) Glutamine metabolism in cancer: understanding the heterogeneity. Trends Cancer 3: 169-180. doi: 10.1016/j.trecan.2017.01.005
[12]
Martinez-Outschoorn UE, Peiris-Pagés M, Pestell RG, et al. (2017) Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol 14: 11-31. doi: 10.1038/nrclinonc.2016.60
[13]
Spinelli JB, Yoon H, Ringel AE, et al. (2017) Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass. Science 358: 941-946. doi: 10.1126/science.aam9305
[14]
Mattaini KR, Sullivan MR, Vander Heiden MG (2016) The importance of serine metabolism in cancer. J Cell Biol 214: 249-257. doi: 10.1083/jcb.201604085
[15]
Danenberg PV (1977) Thymidylate synthetase—A target enzyme in cancer chemotherapy. Biochim Biophys Acta 473: 73-92.
[16]
Mathews CK (2015) Deoxyribonucleotide metabolism, mutagenesis and cancer. Nat Rev Cancer 15: 528-539. doi: 10.1038/nrc3981
[17]
Irwin CR, Hitt MM, Evans DH (2017) Targeting nucleotide biosynthesis: a strategy for improving the oncolytic potential of DNA viruses. Front Oncol 7: 229. doi: 10.3389/fonc.2017.00229
[18]
Shay JW (2016) Role of telomeres and telomerase in aging and cancer. Cancer Discovery 6: 584-593. doi: 10.1158/2159-8290.CD-16-0062
[19]
Sahin E, Colla S, Liesa M, et al. (2011) Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470: 359-365. doi: 10.1038/nature09787
[20]
Houtkooper RH, Mouchiroud L, Ryu D, et al. (2013) Mitochondrial protein imbalance as a conserved longevity mechanism. Nature 497: 451-457. doi: 10.1038/nature12188
[21]
Vogelstein B, Papadopoulos N, Velculescu VE, et al. (2013) Cancer genome landscapes. Science 339: 1546-1558. doi: 10.1126/science.1235122
[22]
Gasparre G, Porcelli AM, Lenaz G, et al. (2014) Relevance of mitochondrial genetics and metabolism in cancer development. Mitochondria Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 235-251.
[23]
Troulinaki K, Bano D (2012) Mitochondrial deficiency: a double-edged sword for aging and neurodegeneration. Front Genet 3: 244. doi: 10.3389/fgene.2012.00244
[24]
Bender DA (2014) Micronutrients. Introduction to nutrition and metabolism Boca Raton, NW: CRC Press, Taylor & Francis Group, 343-349.
Rechsteiner M, Catanzarite V (1974) The biosynthesis and turnover of nicotinamide adenine dinucleotide in enucleated culture cells. J Cell Physiol 84: 409-422. doi: 10.1002/jcp.1040840309
[27]
Tanuma S, Sato A, Oyama T, et al. (2016) New insights into the roles of NAD+-poly (ADP-ribose) metabolism and poly (ADP-ribose) glycohydrolase. Curr Protein Pep Sci 17: 668-682. doi: 10.2174/1389203717666160419150014
[28]
Chen YR (2013) Mitochondrial dysfunction. Basis of oxidative stress: chemistry, mechanisms, and disease pathogenesis Hoboken, NJ: John Wiley & Sons, Inc, 123-135. doi: 10.1002/9781118355886.ch6
[29]
Wünschiers R (2012) Carbohydrate Metabolism and Citrate Cycle. Biochemical Pathways: An Atlas of Biochemistry and Molecular Biology, 2nd ed Hoboken, NJ: John Wiley & Sons, Inc, 37-58.
[30]
Wünschiers R (2012) Nucleotides and Nucleosides. Biochemical Pathways: An Atlas of Biochemistry and Molecular Biology Hoboken, NJ: John Wiley & Sons, Inc, 124-133.
[31]
Chaudhuri AR, Nussenzweig A (2017) The multifaceted roles of PARP1 in DNA repair and chromatin remodeling. Nat Rev Mol Cell Biol 18: 610-621. doi: 10.1038/nrm.2017.53
[32]
Maruta H, Okita N, Takasawa R, et al. (2007) The Involvement of ATP produced via (ADP-ribose) (n) in the maintenance of DNA replication apparatus during DNA Repair. Biol Pharm Bull 30: 447-450. doi: 10.1248/bpb.30.447
[33]
Wright RH, Lioutas A, Le Dily F, et al. (2016) ADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodeling. Science 352: 1221-1225. doi: 10.1126/science.aad9335
[34]
German NJ, Haigis MC (2015) Sirtuins and the metabolic hurdles in cancer. Current Biol 25: R569-R583. doi: 10.1016/j.cub.2015.05.012
[35]
O'Callaghan C, Vassilopoulos A (2017) Sirtuins at the crossroads of stemness, aging, and cancer. Aging Cell 16: 1208-1218. doi: 10.1111/acel.12685
[36]
Hsu WW, Wu B, Liu WR (2016) Sirtuins 1 and 2 are universal histone deacetylases. ASC Chem Biol 11: 792-799.
[37]
Tan B, Young DA, Lu ZH, et al. (2012) Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells. J Biol Chem 288: 3500-3511. doi: 10.1074/jbc.M112.394510
[38]
Cambronne XA, Stewart ML, Kim D, et al. (2016) Biosensor reveals multiple sources for mitochondrial NAD+. Science 352: 1474-1477. doi: 10.1126/science.aad5168
[39]
Berridge G, Cramer R, Galione A, et al. (2002) Metabolism of the novel Ca2+-mobilizing messenger nicotinic acid-adenine dinucleotide phosphate via a 2′-specific Ca2+-dependent phosphatase. Biochem J 365: 295-301. doi: 10.1042/bj20020180
[40]
Tran MT, Zsengeller ZK, Berg AH, et al. (2016) PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection. Nature 531: 528-532. doi: 10.1038/nature17184
[41]
Gujar AD, Le S, Mao DD, et al. (2016) An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. Proc Natl Acad Sci USA 113: E8247-E8256. doi: 10.1073/pnas.1610921114
[42]
Zhao H, Tang W, Chen X, et al. (2017) The NAMPT/E2F2/SIRT1 axis promotes proliferation and inhibits p53-dependent apoptosis in human melanoma cells. Biochem Biophys Res Commun 493: 77-84. doi: 10.1016/j.bbrc.2017.09.071
[43]
Mutz CN, Schwentner R, Aryee DNT, et al. (2017) EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells. Oncotarget 8: 24679-24693. doi: 10.18632/oncotarget.14976
[44]
Tan B, Dong S, Shepard RL, et al. (2015) Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, leads to altered carbohydrate metabolism in cancer cells. J Biol Chem 290: 15812-15824. doi: 10.1074/jbc.M114.632141
[45]
Hufton SE, Moerkerk PT, Brandwijk R, et al. (1999) A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett 463: 77-82. doi: 10.1016/S0014-5793(99)01578-1
[46]
Van Beijnum JR, Moerkerk PT, Gerbers AJ, et al. (2002) Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. Int J Cancer 101: 118-127. doi: 10.1002/ijc.10584
[47]
Bi TQ, Che XM, Liao XH, et al. (2011) Over expression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil. Oncol Rep 26: 1251-1257.
[48]
Ogino Y, Sato A, Uchiumi F, et al. (2018) Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment. Oncotarget 9: 16451-16461. doi: 10.18632/oncotarget.24731
[49]
Chowdhry S, Zanca C, Rajkumar U, et al. (2019) NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling. Nature 569: 570-575. doi: 10.1038/s41586-019-1150-2
[50]
Ulanovskaya OA, Zhul AM, Cravatt BF (2013) NNMT promotes epigenetic remodelling in cancer by creating a metabolic methylation sink. Nat Chem Biol 9: 300-306. doi: 10.1038/nchembio.1204
[51]
Eckert MA, Coscia F, Chryplewicz A, et al. (2019) Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Nature 569: 723-728. doi: 10.1038/s41586-019-1173-8
[52]
Cantó C, Houtkooper RH, Pirinen E, et al. (2012) The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 15: 838-847. doi: 10.1016/j.cmet.2012.04.022
[53]
Han X, Tai H, Wang X, et al. (2016) AMPK activation protects cells from oxidative stress-induced senescence via autophagic flux restoration and intracellular NAD elevation. Aging Cell 15: 416-427. doi: 10.1111/acel.12446
[54]
Yang Y, Sauve AA (2016) NAD+ metabolism: bioenergetics, signaling and manipulation for therapy. Biochim Biophys Acta 1864: 1787-1800. doi: 10.1016/j.bbapap.2016.06.014
[55]
Zhang H, Ryu D, Wu Y, et al. (2016) NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 352: 1436-1443. doi: 10.1126/science.aaf2693
[56]
Rehmani I, Liu F, Liu A (2013) Cell signaling and transcription. Molecular basis of oxidative stress: chemistry, mechanisms, and disease pathogenesis Hoboken, NJ: John Wiley & Sons, 179-201. doi: 10.1002/9781118355886.ch8
López-Otín C, Serrano M, Partridge L, et al. (2013) The hallmarks of aging. Cell 153: 1194-1217. doi: 10.1016/j.cell.2013.05.039
[59]
Santidrian AF, Matsuno-Yagi A, Ritland M, et al. (2013) Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Invest 123: 1068-1081. doi: 10.1172/JCI64264
[60]
Luo C, Lim JH, Lee Y, et al. (2016) PGC1α-mediated transcriptional axis suppresses melanoma metastasis. Nature 537: 422-426. doi: 10.1038/nature19347
[61]
Kamenisch Y, Fousteri M, Knoch J, et al. (2010) Proteins of nucleotide and base excision repair pathways interact in mitochondria to protect from loss of subcutaneous fat, a hallmark of aging. J Exp Med 207: 379-390. doi: 10.1084/jem.20091834
[62]
Guarente L (2014) Linking DNA damage, NAD+/SIRT1, and aging. Cell Metab 20: 706-707. doi: 10.1016/j.cmet.2014.10.015
[63]
Dang L, White DW, Gross S, et al. (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462: 739-744. doi: 10.1038/nature08617
[64]
Yan H, Parsons DW, Jin G, et al. (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360: 765-773. doi: 10.1056/NEJMoa0808710
[65]
Lu C, Ward PS, Kapoor GS, et al. (2012) IDH mutation impairs histonedemethylation and results in a block to cell differentiation. Nature 483: 474-478. doi: 10.1038/nature10860
[66]
Uchiumi F, Larsen S, Tanuma S (2013) Transcriptional regulation of the human genes that encode DNA repair- and mitochondrial function-associated proteins. Advances in DNA Repair Rijeka, Croatia: InTech Open Access Publisher, 129-167.
[67]
Gray LR, Tompkins SC, Taylor EB (2014) Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci 71: 2577-2604. doi: 10.1007/s00018-013-1539-2
[68]
Behl C, Ziegler C (2014) Selected age-related disorders. Cell Aging: Molecular Mechanisms and Implications for Disease Heidelberg, Germany: Springer Briefs in Molecular Medicine, Springer Science+Business Media, 99-108. doi: 10.1007/978-3-642-45179-9_4
[69]
Bender A, Krishnan KJ, Morris CM, et al. (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38: 515-517. doi: 10.1038/ng1769
[70]
Ansari A, Rahman MS, Saha SK, et al. (2017) Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease. Aging Cell 16: 4-16. doi: 10.1111/acel.12538
[71]
Salvatori I, Valle C, Ferri A, et al. (2018) SIRT3 and mitochondrial metabolism in neurodegenerative diseases. Neurochem Int 109: 184-192. doi: 10.1016/j.neuint.2017.04.012
[72]
Patel NV, Gordon MN, Connor KE, et al. (2005) Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models. Neurobiol Aging 26: 995-1000. doi: 10.1016/j.neurobiolaging.2004.09.014
[73]
Imai S, Guarente L (2010) Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci 31: 212-220. doi: 10.1016/j.tips.2010.02.003
[74]
Silva DF, Esteves AR, Oliveira CR, et al. (2017) Mitochondrial metabolism power SIRT2-dependent traffic causing Alzheimer's-disease related pathology. Mol Neurobiol 54: 4021-4040. doi: 10.1007/s12035-016-9951-x
[75]
Jung ES, Choi H, Song H, et al. (2016) p53-dependent SIRT6 expression protects Ab42-induced DNA damage. Sci Rep 6: 25628. doi: 10.1038/srep25628
[76]
Blakey CA, Litt MD (2016) Epigenetic gene expression-an introduction. Epigenetic gene expression and regulation London, UK: Academic Press, Elsevier Inc, 1-19.
[77]
Suvà ML, Riggi N, Bernstein BE (2013) Epigenetic reprogramming in cancer. Science 339: 1567-1570. doi: 10.1126/science.1230184
[78]
McDevitt MA (2016) Clinical applications of epigenetics. Epigenomics in health and disease San Diego, CA: Academic Press, 271-295. doi: 10.1016/B978-0-12-800140-0.00013-3
[79]
Hentze MW, Preiss T (2010) The REM phase of gene regulation. Trends Biochem Sci 35: 423-426. doi: 10.1016/j.tibs.2010.05.009
[80]
Gut P, Verdin E (2013) The nexus of chromatin regulation and intermediary metabolism. Nature 502: 489-498. doi: 10.1038/nature12752
[81]
Liu C, Vyas A, Kassab MA, et al. (2017) The role of poly ADP-ribosylation in the first wave of DNA damage response. Nucleic Acids Res 45: 8129-8141. doi: 10.1093/nar/gkx565
[82]
Bai P, Cantó C, Oudart H, et al. (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13: 461-468. doi: 10.1016/j.cmet.2011.03.004
[83]
Baxter P, Chen Y, Xu Y, et al. (2014) Mitochondrial dysfunction induced by nuclear poly (ADP-ribose) polymerase-1: a treatable cause of cell death in stroke. Transl Stroke Res 5: 136-144. doi: 10.1007/s12975-013-0283-0
[84]
Uchiumi F, Watanabe T, Ohta R, et al. (2013) PARP1 gene expression is downregulated by knockdown of PARG gene. Oncol Rep 29: 1683-1688. doi: 10.3892/or.2013.2321
[85]
Gibson BA, Zhang Y, Jiang H, et al. (2016) Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation. Science 353: 45-50. doi: 10.1126/science.aaf7865
[86]
Uchiumi F, Fujikawa M, Miyazaki S, et al. (2013) Implication of bidirectional promoters containing duplicated GGAA motifs of mitochondrial function-associated genes. AIMS Mol Sci 1: 1-26. doi: 10.3934/molsci.2013.1.1
[87]
Desquiret-Dumas V, Gueguen N, Leman G, et al. (2013) Resveratrol induces a mitochondrial complex I dependent increase in NADH oxidation responsible for sirtuin activation in liver cells. J Biol Chem 288: 36662-36675. doi: 10.1074/jbc.M113.466490
[88]
Liu J, Oberdoerffer P (2013) Metabolic modulation of chromatin: implications for DNA repair and genomic integrity. Front Genet 4: 182.
[89]
Pearce EL, Poffenberger MC, Chang CH, et al. (2013) Fueling Immunity: Insights into metabolism and lymphocyte function. Science 342: 1242454. doi: 10.1126/science.1242454
[90]
Uchiumi F, Shoji K, Sasaki Y, et al. (2015) Characterization of the 5′-flanking region of the human TP53 gene and its response to the natural compound, Resveratrol. J Biochem 159: 437-447. doi: 10.1093/jb/mvv126
[91]
Di LJ, Fernandez AG, de Siervi A, et al. (2010) Transcriptional regulation of BRCA1 expression by a metabolic switch. Nat Struct Mol Biol 17: 1406-1413. doi: 10.1038/nsmb.1941
[92]
Chinnadurai G (2002) CtBP, an unconventional transcription corepressor in development and oncogenesis. Mol Cell 9: 213-224. doi: 10.1016/S1097-2765(02)00443-4
[93]
Chinnadurai G (2009) The transcription corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res 69: 731-734. doi: 10.1158/0008-5472.CAN-08-3349
[94]
Shen Y, Kapfhamer D, Minnella AM, et al. (2017) Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP. Nat Commun 8: 624. doi: 10.1038/s41467-017-00707-0
[95]
Chen YQ, Sengchanthalangsy LL, Hackett A, et al. (2000) NF-kappaB p65 (RelA) homodimer uses distinct mechanisms to recognize DNA targets. Structure 8: 419-428. doi: 10.1016/S0969-2126(00)00123-4
[96]
Yang ZF, Drumea K, Mott S, et al. (2014) GABP transcription factor (nuclear respiratory factor 2) is required for mitochondrial biogenesis. Mol Cell Biol 34: 3194-3201. doi: 10.1128/MCB.00492-12
[97]
Keckesova Z, Donaher JL, De Cock J, et al. (2017) LACTB is a tumor suppressor that modulates lipid metabolism and cell state. Nature 543: 681-686. doi: 10.1038/nature21408
[98]
Venigopal R, Jaiswal AK (1996) Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P): quinone oxidoreductase1 gene. Proc Natl Acad Sci USA 93: 14960-14965. doi: 10.1073/pnas.93.25.14960
[99]
Wilson LA, Germin A, Espiritu R, et al. (2005) Ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element. FASEB J 19: 2085-2087. doi: 10.1096/fj.05-4401fje
[100]
Wei GH, Badis G, Berger MF, et al. (2010) Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J 29: 2147-2160. doi: 10.1038/emboj.2010.106
[101]
Houtkooper RH, Pirinen E, Auwerx J (2012) Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13: 225-238. doi: 10.1038/nrm3293
[102]
Sabari BR, Zhang D, Allis CD, et al. (2017) Metabolic regulation of gene expression through histone acylations. Nat Rev Mol Cell Biol 18: 90-101. doi: 10.1038/nrm.2016.140
[103]
Limagne E, Thibaudin M, Euvrard R, et al. (2017) Sirtuin-1 activation controls tumor growth by impeding Th17 differentiation via STAT3 deacetylation. Cell Rep 19: 746-759. doi: 10.1016/j.celrep.2017.04.004
[104]
Bonkowski MS, Sinclair DA (2016) Slowing aging by design: the rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell Biol 17: 679-690. doi: 10.1038/nrm.2016.93
[105]
Menzies KJ, Singh K, Saleem A, et al. (2013) Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis. J Biol Chem 288: 6968-6979. doi: 10.1074/jbc.M112.431155
[106]
Sack MN, Finkel T (2014) Mitochondrial metabolism, sirtuins, and aging. Mitochondria Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 253-262.
[107]
Gibson BA, Kraus WL (2012) New insights into the molecular and cellular functions of poly (ADP-ribose) and PARPs. Nat Rev Mol Cell Biol 13: 411-424. doi: 10.1038/nrm3376
[108]
Curtin NJ, Mukhopadhyay A, Drew Y, et al. (2012) The role of PARP in DNA repair and its therapeutic exploitation. DNA repair in cancer therapy-Molecular targets and clinical applications London, UK: Academic Press, Elsevier Inc, 55-73. doi: 10.1016/B978-0-12-384999-1.10004-6
[109]
Lord CJ, Ashworth A (2017) PARP inhibitors: Synthetic lethality in the clinic. Science 355: 1152-1158. doi: 10.1126/science.aam7344
[110]
Venkitaraman AR (2014) Cancer suppression by the chromosome custodians, BRCA1 and BRCA2. Science 343: 1470-1475. doi: 10.1126/science.1252230
[111]
Feng X, Koh DW (2013) Inhibition of poly (ADP-ribose) polymerase-1 or poly (ADP-ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells. Int J Oncol 42: 749-756. doi: 10.3892/ijo.2012.1740
[112]
Gomes AP, Price NL, Ling AJY, et al. (2013) Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155: 1624-1638. doi: 10.1016/j.cell.2013.11.037
Williams PA, Harder JM, Foxworth NE, et al. (2017) Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science 355: 756-760. doi: 10.1126/science.aal0092
[115]
Sueishi Y, Nii R, Kakizaki N (2017) Resveratrol analogues like piceatannol are antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. Bioorg Med Chem Lett 27: 5203-5206. doi: 10.1016/j.bmcl.2017.10.045
[116]
Johnson SC, Yanos ME, Kayser EB, et al. (2013) mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science 342: 1524-1528. doi: 10.1126/science.1244360
[117]
Fendt SM, Bell EL, Keibler MA, et al. (2013) Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. Cancer Res 73: 4429-4438. doi: 10.1158/0008-5472.CAN-13-0080
[118]
Yamato M, Kawano K, Yamanaka Y, et al. (2016) TEMPOL increases NAD+ and improves redox imbalance in obese mice. Redox Biol 8: 316-322. doi: 10.1016/j.redox.2016.02.007
[119]
Jackson SJT, Singletary KW, Murphy LL, et al. (2016) Phytonutrients differentially stimulate NAD(P)H: quinone oxidoreductase, inhibit proliferation, and trigger mitotic catastrophe in Hepa1c1c7 cells. J Med Food 19: 47-53. doi: 10.1089/jmf.2015.0079
[120]
Roubalová L, Dinkova-Kostova AT, Biedermann D, et al. (2017) Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H: quinone oxidoreductase 1 in Hepa1c1c7 cells. Fitoterapia 119: 115-120. doi: 10.1016/j.fitote.2017.04.012
[121]
Son MJ, Ryu JS, Kim JY, et al. (2017) Upregulation of mitochondrial NAD+ levels impairs the clonogenicity of SSEA1+ glioblastoma tumor-initiating cells. Exp Mol Med 49: e344. doi: 10.1038/emm.2017.74
[122]
Fang EF, Kassahun H, Croteau DL, et al. (2016) NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia model via mitophagy and DNA repair. Cell Metab 24: 566-581. doi: 10.1016/j.cmet.2016.09.004
[123]
Takihara Y, Sudo D, Arakawa J, et al. (2018) Nicotinamide adenine dinucleotide (NAD+) and cell aging. New Research on Cell Aging and Death Hauppauge, NY: Nova Science Publishers, Inc, 131-158.
[124]
Wartewig T, Kurgyis Z, Keppler S, et al. (2017) PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis. Nature 552: 121-125. doi: 10.1038/nature24649
[125]
Uchiumi F, Larsen S, Tanuma S (2016) Possible roles of a duplicated GGAA motif as a driver cis-element for cancer-associated genes. Understand Cancer – Research and Treatment Hong Kong: iConcept Press Ltd, 1-25.
[126]
Uchiumi F, Larsen S, Masumi A, et al. (2013) The putative implications of duplicated GGAA-motifs located in the human interferon regulated genes (ISGs). Genomics I-Humans, Animals and Plants Hong Kong: iConcept Press Ltd, 87-105.
[127]
Uchiumi F, Arakawa J, Iwakoshi K, et al. (2016) Characterization of the 5′-flanking region of the human DNA helicase B (HELB) gene and its response to trans-resveratrol. Sci Rep 6: 24510. doi: 10.1038/srep24510
This article has been cited by:
1.
Yuan Tian, Hua Guo, Wenyu Shen, Xinrui Yan, Jie Zheng, Kaibiao Sun,
Dynamic analysis and validation of a prey-predator model based on fish harvesting and discontinuous prey refuge effect in uncertain environments,
2025,
33,
2688-1594,
973,
10.3934/era.2025044
Interspecific competition between prey x1 and prey x2
c1,c2
Predation coefficients for prey x1 and prey x2
m1,m2
Refuge rates of prey x1 and prey x2
e1,e2
Conversion factors for prey x1 and prey x2
q1,q2,q3
Captureability factors for prey x1, prey x2 and predator y
E1,E2,E3
Harvesting efforts for prey x1, prey x2 and predator y
d
Predator y mortality rate
w1
w2
P1 at α=0
P1 at α=0.3
P1 at α=0.6
P1 at α=0.9
0
1
(0,0,0)
(0,0,0)
(0,0,0)
(0,0,0)
0.2
0.8
(0,0,0)
(0,0,0)
(0,0,0)
(0,0,0)
0.4
0.6
(0,0,0)
(0,0,0)
(0,0,0)
(0,0,0)
0.6
0.4
(0,0,0)
(0,0,0)
(0,0,0)
(0,0,0)
0.8
0.2
(0,0,0)
(0,0,0)
(0,0,0)
(0,0,0)
1
0
(0,0,0)
(0,0,0)
(0,0,0)
(0,0,0)
w1
w2
P2 at α=0
P2 at α=0.3
P2 at α=0.6
P2 at α=0.9
0
1
(5.3393,0,0)
(5.1224,0,0)
(4.9144,0,0)
(4.7148,0,0)
0.2
0.8
(5.0521,0,0)
(4.9280,0,0)
(4.8069,0,0)
(4.6888,0,0)
0.4
0.6
(4.7804,0,0)
(4.7409,0,0)
(4.7017,0,0)
(4.6629,0,0)
0.6
0.4
(4.5230,0,0)
(4.5608,0,0)
(4.5988,0,0)
(4.6372,0,0)
0.8
0.2
(4.2788,0,0)
(4.3872,0,0)
(4.4980,0,0)
(4.6116,0,0)
1
0
(4.0469,0,0)
(4.2197,0,0)
(4.3994,0,0)
(4.5861,0,0)
w1
w2
P3 at α=0
P3 at α=0.3
P3 at α=0.6
P3 at α=0.9
0
1
(0,5.5357,0)
(0,5.3147,0)
(0,5.1027,0)
(0,4.8993,0)
0.2
0.8
(0,5.2431,0)
(0,5.1166,0)
(0,4.9932,0)
(0,4.8728,0)
0.4
0.6
(0,4.9662,0)
(0,4.9260,0)
(0,4.8861,0)
(0,4.8465,0)
0.6
0.4
(0,4.7039,0)
(0,4.7424,0)
(0,4.7812,0)
(0,4.8202,0)
0.8
0.2
(0,4.4551,0)
(0,4.5655,0)
(0,4.6785,0)
(0,4.7942,0)
1
0
(0,4.2187,0)
(0,4.3949,0)
(0,4.5779,0)
(0,4.7682,0)
w1
w2
P4 at α=0
P4 at α=0.3
P4 at α=0.6
P4 at α=0.9
0
1
(0.4800,0,0.1496)
(0.5838,0,0.1767)
(0.7059,0,0.2040)
(0.8516,0,0.2317)
0.2
0.8
(0.6222,0,0.1858)
(0.6971,0,0.2022)
(0.7802,0,0.2188)
(0.8732,0,0.2354)
0.4
0.6
(0.8000,0,0.2224)
(0.8306,0,0.2280)
(0.8623,0,0.2335)
(0.8954,0,0.2391)
0.6
0.4
(1.0286,0,0.2595)
(0.9902,0,0.2539)
(0.9534,0,0.2484)
(0.9181,0,0.2428)
0.8
0.2
(1.3333,0,0.2969)
(1.1845,0,0.2801)
(1.0551,0,0.2633)
(0.9415,0,0.2465)
1
0
(1.7600,0,0.3343)
(1.4261,0,0.3062)
(1.1692,0,0.2782)
(0.9655,0,0.2502)
w1
w2
P5 at α=0
P5 at α=0.3
P5 at α=0.6
P5 at α=0.9
0
1
(0,0.1920,0.3638)
(0,0.2298,0.3833)
(0,0.2727,0.4029)
(0,0.3220,0.4226)
0.2
0.8
(0,0.2435,0.3899)
(0,0.2697,0.4016)
(0,0.2981,0.4134)
(0,0.3291,0.4252)
0.4
0.6
(0,0.3048,0.4160)
(0,0.3150,0.4199)
(0,0.3255,0.4239)
(0,0.3363,0.4278)
0.6
0.4
(0,0.3789,0.4422)
(0,0.3668,0.4383)
(0,0.3551,0.4343)
(0,0.3437,0.4304)
0.8
0.2
(0,0.4706,0.4683)
(0,0.4268,0.4566)
(0,0.3872,0.4448)
(0,0.3513,0.4330)
1
0
(0,0.5867,0.4942)
(0,0.4970,0.4748)
(0,0.4222,0.4553)
(0,0.3590,0.4357)
w1
w2
P6 at α=0
P6 at α=0.3
P6 at α=0.6
P6 at α=0.9
0
1
(4.9826,3.8455,0)
(4.6419,3.5356,0)
(4.3385,3.2568,0)
(4.0671,3.0043,0)
0.2
0.8
(4.5369,3.4395,0)
(4.3577,3.2745,0)
(4.1901,3.1191,0)
(4.0331,2.9724,0)
0.4
0.6
(4.1543,3.0858,0)
(4.1016,3.0366,0)
(4.0500,2.9883,0)
(3.9995,2.9408,0)
0.6
0.4
(3.8232,2.7740,0)
(3.8700,2.8184,0)
(3.9177,2.8636,0)
(3.9665,2.9097,0)
0.8
0.2
(3.5351,2.4958,0)
(3.6599,2.6172,0)
(3.7926,2.7447,0)
(3.9338,2.8789,0)
1
0
(3.2834,2.2448,0)
(3.4690,2.4307,0)
(3.6742,2.6311,0)
(3.9017,2.8485,0)
w1
w2
P7 at α=0
P7 at α=0.3
0
1
(1.7240,3.6276,1.1986)
(1.5910,3.4597,1.0271)
0.2
0.8
(1.6168,3.5123,1.0583)
(1.5042,3.3223,0.9139)
0.4
0.6
(1.5417,3.4296,0.9337)
(1.4211,3.1793,0.8023)
0.6
0.4
(1.4309,3.2886,0.7930)
(1.3913,3.1413,0.7269)
0.8
0.2
(1.4291,3.2451,0.6884)
(1.3195,3.0467,0.6350)
1
0
(1.3764,2.9890,0.5245)
(1.2797,2.9766,0.5529)
w1
w2
P7 at α=0.6
P7 at α=0.9
0
1
(1.7066,3.7444,1.0113)
(1.5325,3.4231,0.7999)
0.2
0.8
(1.5291,3.4203,0.8678)
(1.4899,3.3773,0.7762)
0.4
0.6
(1.5273,3.4215,0.8306)
(1.4789,3.3677,0.7638)
0.6
0.4
(1.4894,3.3737,0.7779)
(1.4685,3.3587,0.7516)
0.8
0.2
(1.4594,3.3320,0.7279)
(1.4590,3.3504,0.7397)
1
0
(1.4328,3.2552,0.6687)
(1.4124,3.2841,0.7105)
Figure 1. Biosynthesis and metabolism of NAD+ in eukaryotic cells. [The biosynthetic pathway of the NAD+ molecule in eukaryotic cells is shown. The enzymes that catalyze the reactions are shown by blue characters. NMNATs are encoded by three different genes, NMNAT1 (GENE ID: 64802), NMNAT2 (GENE ID: 23057), and NMNAT3 (GENE ID: 349565). NRKs are encoded by two different genes, NMRK1 (GENE ID: 54981) and NMRK2 (GENE ID: 27231).]
Figure 2. Human TCA cycle-associated protein-encoding genes that have duplicated GGAA motifs near the transcription start site